Investor Overview

Download Corporate Governance Documentation CryoLife Corporate Presentation
Corporate Profile

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries.  It operates throughout the U.S. and internationally.  CryoLife manufactures and distributes BioGlue® Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels.  BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world.  CryoLife’s BioFoam® Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical.  CryoLife distributes PerClot®, a powdered hemostat, in Europe and other select international countries. . . More >>

CRY (Common Stock)
ExchangeNYSE (US Dollar)
Price$16.75
Change (%) Stock is Down 0.4 (2.33%)
Volume33,122
Data as of 03/27/17 2:05 p.m. ET
Refresh quote
Recent NewsMore >>
DateTitle
02/15/17CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results
02/07/17CryoLife Announces Release Date and Teleconference Call Details for 2016 Fourth Quarter and Year-End Financial Results
11/10/16CryoLife to Present at Two Investor Conferences in November 2016
Upcoming EventsMore >>
There are currently no events scheduled.
Most Recent SEC FilingsMore >>
Filing DateFormDescriptionFiling GroupDownloads
03/23/178-KReport of unscheduled material events or corporate eventCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
03/16/178-KReport of unscheduled material events or corporate eventCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/28/174Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/28/174Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/28/174Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
Data provided by Nasdaq. Minimum 15 minutes delayed.
Receive E-mail Alerts
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!